Board meeting on 4 Aug 2026 to approve Q1 FY27 results

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.0%1-day move

₹0.56

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+0.0+0.0+0.0-1.8——————

Up moveDown movePending

AI summary

Shree Ganesh Biotech has informed exchanges that its Board of Directors will meet on Tuesday, 4 August 2026, to consider and approve the Unaudited Financial Results for Q1 ending 30 June 2026. The meeting may also cover other matters with board approval. Filing made under SEBI LODR Regulation 29.

Likely market impact

Routine regulatory intimation. Q1 results may influence sentiment based on performance versus expectations. No immediate share price trigger expected.